Meeting
2023 ASCO Annual Meeting
Prognostic factors for relapse in patients with clinical stage I testicular seminoma: A nationwide, population-based cohort study.
Authors
Thomas Wagner
Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
Thomas Wagner , Birgitte Grønkær Toft , Jakob Lauritsen , Mikkel Bandak , Ib Jarle Christensen , Birte Engvad , Michael Kreiberg Jessen , Mads Agerbaek , Lars Dysager , Josephine Rosenvilde , Daniel Berney , Gedske Daugaard
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Germ Cell/Testicular Cancer
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 5041)
DOI
10.1200/JCO.2023.41.16_suppl.5041
Abstract #
5041
Poster Bd #
135
Abstract Disclosures
Similar Posters
Poster
2014 Genitourinary Cancers Symposium
Craniocaudal retroperitoneal node length as a risk factor for relapse from clinical stage I testicular germ cell tumor.
First Author: Stephanie Anne Holler Howard
Poster
2011 Genitourinary Cancers Symposium
Surveillance for stage I testicular seminoma at a single institution in Japan: Retrospective analysis of prognostic factors for relapse.
First Author: Ken-Ichi Kakimoto
Poster
2024 ASCO Genitourinary Cancers Symposium
Association of DAZL expression with risk of recurrence in clinical stage 1 testicular germ cell tumors.
First Author: Alok Tewari
Poster
2023 ASCO Annual Meeting
AGCT1531: Evaluating the utility of circulating microRNA in the management of children, adolescents, and adults with malignant germ cell tumors.
First Author: Furqan Shaikh